Our findings provide a new insight that the inhibition of M1 cytokine expression in adipose tissue with non-diabetic plasma may represent a novel therapeutic approach for attenuating DPP4 activity, systemic inflammation, and insulin resistance in diabetic patients. This evidence concerns the gene DPP4 and Insulin resistance.